Skip to main content
OpenTrials

Clinical trial condition

Stage IV Breast Cancer AJCC v6 and v7

Explore clinical trials studying Stage IV Breast Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

39 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Breast Cancer AJCC v6 and v7 trial results

Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

NCT02971761

Conditions
Androgen Receptor Positive, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope Mission Hills Mission Hills, California, United States
View Trial Details
Completed

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

NCT03477396

Conditions
Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope Mission Hills Mission Hills, California, United States
View Trial Details
Completed

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

NCT01142401

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Carcinoma, +7 more
Locations
  • University of Connecticut Farmington, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • Cleveland Clinic-Weston Weston, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 21 locations
View Trial Details
Completed

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

NCT01622868

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 302 locations
View Trial Details
Completed

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

NCT02673398

Conditions
HER2 Positive Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope Mission Hills Mission Hills, California, United States
View Trial Details
Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

NCT00684983

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +9 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Mills-Peninsula Medical Center Burlingame, California, United States
View all 390 locations
View Trial Details

Related conditions